| Entry |
|
|---|
| Name |
Epoprostenol sodium (JAN/USAN);
Flolan (TN);
Veletri (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C20H31O5. Na
|
|---|
| Exact mass |
374.2069
|
|---|
| Mol weight |
374.45
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
Hormonal agent
DG01961 Prostaglandin derivative
DG01810 Prostacycline derivative
|
|---|
| Remark |
| Therapeutic category: | 2190 |
| Product (DG00157): | D01337<JP/US> |
|
|---|
| Efficacy |
Antihypertensive, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist |
|---|
| Disease |
Pulmonary arterial hypertension [DS: H01621] |
|---|
| Comment |
Prostacycline derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07228 | Eicosanoid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC09 Epoprostenol
D01337 Epoprostenol sodium (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Prostacyclin Vasodilators
Epoprostenol
D01337 Epoprostenol sodium (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D01337 Epoprostenol sodium (JAN/USAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00157 Epoprostenol
D01337 Epoprostenol sodium
Hormonal agent
DG01961 Prostaglandin derivative
DG01810 Prostacycline derivative
DG00157 Epoprostenol
D01337 Epoprostenol sodium
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostacyclin
PTGIR
D01337 Epoprostenol sodium (JAN/USAN) <JP/US>
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00157 Epoprostenol
Hormonal agent
DG01961 Prostaglandin derivative
DG01810 Prostacycline derivative
DG00157 Epoprostenol
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 Z Na 26.1044 -10.2395 #+
2 C1y C 25.1300 -19.0400
3 C1y C 23.8000 -18.6200
4 C1y C 25.1300 -20.4400
5 C1x C 25.8300 -17.7800
6 O2x O 23.8000 -17.1500
7 C1x C 23.0300 -19.7400
8 C1y C 23.8700 -20.8600
9 C2b C 26.3200 -21.1400
10 C2y C 25.1300 -16.5200
11 O1a O 23.3800 -22.1900
12 C2b C 27.5100 -20.4400
13 C2b C 26.3200 -15.8200
14 C1c C 28.7000 -21.1400
15 C1b C 29.9600 -20.4400
16 O1a O 28.7000 -22.4700
17 C1b C 31.1500 -21.1400
18 C1b C 32.3400 -20.4400
19 C1b C 33.5300 -21.1400
20 C1a C 34.7200 -20.4400
21 C1b C 26.3900 -14.4200
22 C1b C 27.5800 -13.7200
23 C1b C 27.5800 -12.3200
24 C6a C 28.7700 -11.6200
25 O6a O 30.0300 -12.3200
26 O6a O 28.7700 -10.2200 #-
BOND 26
1 2 3 1
2 2 4 1
3 2 5 1 #Down
4 3 6 1 #Down
5 3 7 1
6 4 8 1
7 4 9 1 #Up
8 5 10 1
9 8 11 1 #Down
10 9 12 2
11 10 13 2
12 12 14 1
13 14 15 1
14 14 16 1 #Down
15 15 17 1
16 17 18 1
17 18 19 1
18 19 20 1
19 6 10 1
20 7 8 1
21 13 21 1
22 21 22 1
23 22 23 1
24 23 24 1
25 24 25 2
26 24 26 1
|
|---|
